LGVNR (LGVNR) News
Follow LGVNR (LGVNR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
LGVN LGVNR - Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
LGVN LGVNR - Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
NEWS | Sep 16, 2026, 09:27 PM UTC
L
LGVN LGVNR - Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
LGVN LGVNR - Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
EQUITY | Sep 03, 2026, 01:15 PM UTC
L
Longeveron Announces 1-for-10 Reverse Stock Split
Longeveron announced a 1-for-10 reverse stock split for LGVNR.
EQUITY | Aug 24, 2026, 08:05 PM UTC
M
Longeveron appoints Nirav Jhaveri as Chief Financial Officer
Longeveron (LGVNR) appoints Nirav Jhaveri as its Chief Financial Officer, according to the company’s announcement.
EQUITY | Aug 19, 2026, 08:05 PM UTC
L
Longeveron Announces Q2 Financial Results
Longeveron announces 2026 second quarter financial results and provides business update
EARNINGS | Aug 12, 2026, 08:05 PM UTC
L
LGVN LGVNR - Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
LGVN LGVNR - Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
EARNINGS | Aug 03, 2026, 08:05 PM UTC